Search

Your search keyword '"Fenofibrate -- Intellectual property"' showing total 73 results
Start Over Descriptor "Fenofibrate -- Intellectual property"
73 results on '"Fenofibrate -- Intellectual property"'

2. Researchers Submit Patent Application, 'Preparation Of Lipophilic Active Ingredients', for Approval (USPTO 20240082157)

Subjects
Fenofibrate -- Intellectual property, Halofantrine -- Intellectual property, Darunavir, Clopidogrel -- Intellectual property, Dutasteride -- Intellectual property, Physical fitness, Health
Abstract

2024 APR 6 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2024

3. GUATEMALAN INSTITUTE OF SOCIAL SECURITY -IGSS- invites tenders for Order No. 17927/2024; Igss Code: 75900; Fenofibrate, 160 Mg Capsules with Enteric Granules; Trademark Controlip

Subjects
Fenofibrate -- Intellectual property, Trademarks, News, opinion and commentary
Abstract

GUATEMALAN INSTITUTE OF SOCIAL SECURITY -IGSS-, Guatemala has invited tenders for Order No. 17927/2024; Igss Code: 75900; Fenofibrate, 160 Mg Capsules with Enteric Granules; Trademark Controlip. Tender Notice No: 23445440 [...]

Published
2024

4. Patent Issued for Prophylactic and therapeutic drug for nonalcoholic fatty liver disease (USPTO 12042483)

Subjects
Kowa Company Ltd. -- Intellectual property, Fenofibrate -- Intellectual property, Diseases -- Japan, Fatty liver, Pharmaceutical industry -- Intellectual property, Health
Abstract

2024 AUG 12 (NewsRx) -- By a News Reporter-Staff News Editor at Hepatitis Weekly -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the [...]

Published
2024

6. Patent Application Titled 'Combination Medicine For Preventing/Treating Dyslipidemia Or Cardiovascular Disease' Published Online (USPTO 20240197688)

Subjects
Fenofibrate -- Intellectual property, Heart attack, Antilipemic agents -- Intellectual property, Cardiovascular diseases, Biotechnology industry, Pharmaceuticals and cosmetics industries, Health
Abstract

2024 JUL 14 (NewsRx) -- By a News Reporter-Staff News Editor at Heart Disease Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2024

7. Patent Issued for Combination therapy comprising an ACC inhibitor (USPTO 11963961)

Subjects
Gilead Sciences Inc. -- Intellectual property, Biological products industry -- Intellectual property, Fenofibrate -- Intellectual property, Liver, Liver diseases, Type 2 diabetes, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2024 MAY 15 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- A patent by the inventors Bates, Jamie Geier (Burlingame, CA, US), Ray, Adrian S. (Belmont, [...]

Published
2024

8. Patent Issued for Self-emulsifying composition of o-3 fatty acid (USPTO 11911480)

Subjects
Mochida Pharmaceutical Company Ltd. -- Intellectual property, Fenofibrate -- Intellectual property, Unsaturated fatty acids -- Intellectual property, Alcohols -- Intellectual property, Pharmaceutical industry -- Intellectual property, Business, Health
Abstract

2024 MAR 22 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- Mochida Pharmaceutical Co. Ltd. (Tokyo, Japan) has been issued patent number 11911480, according [...]

Published
2024

12. Researchers Submit Patent Application, 'Concentrate Containing Poorly Soluble Drug And Emulsion Prepared Therefrom', for Approval (USPTO 20230398072)

Subjects
Fenofibrate -- Intellectual property, Vincristine -- Intellectual property, Posaconazole, Drug approval, Clopidogrel -- Intellectual property, Adefovir dipivoxil -- Intellectual property, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

2024 JAN 1 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors CHENG, [...]

Published
2024

14. Patent Application Titled 'Pharmaceutical Formulation with Improved Solubility and Bioavailability' Published Online (USPTO 20210267898)

Subjects
Nilotinib, Patient compliance, Antineoplastic agents -- Intellectual property, Rifabutin -- Intellectual property, Valsartan, Physical fitness, Telmisartan -- Intellectual property, Antimitotic agents -- Intellectual property, Fenofibrate -- Intellectual property, Tinidazole -- Intellectual property, Carisoprodol -- Intellectual property, Clopidogrel -- Intellectual property, Lamotrigine -- Intellectual property, Health
Abstract

2021 SEP 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2021

17. Patent Application Titled 'Pld For Use In Combination In The Treatment Of Coronavirus' Published Online (USPTO 20230158103)

Subjects
Fenofibrate -- Intellectual property, Tofacitinib, Ciclesonide, Darunavir, Aprotinin, Coronaviruses, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

2023 JUN 12 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2023

18. Researchers Submit Patent Application, 'Topical Formulations Having Enhanced Bioavailability', for Approval (USPTO 20230147697)

Subjects
Oxaprozin -- Intellectual property, Halofantrine -- Intellectual property, Sibutramine -- Intellectual property, Tizanidine -- Intellectual property, Valsartan, Nalbuphine -- Intellectual property, Anticonvulsants -- Intellectual property, Rifapentine -- Intellectual property, Telmisartan -- Intellectual property, Clemastine -- Intellectual property, Fenofibrate -- Intellectual property, Dirithromycin -- Intellectual property, Efavirenz -- Intellectual property, Metronidazole -- Intellectual property, Butenafine -- Intellectual property, Zileuton -- Intellectual property, Paricalcitol, Health
Abstract

2023 MAY 29 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity & Diabetes Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors [...]

Published
2023

20. Researchers Submit Patent Application, 'Repurposcins: Targeted Inhibitors Of Mitochondrial Biogenesis For Eradicating Cancer Stem Cells', for Approval (USPTO 20200360411)

Subjects
Cancer treatment, Tetracyclines -- Intellectual property, Pyrvinium -- Intellectual property, Cancer, Women's health, Cancer research, Kinase inhibitors -- Intellectual property, Stem cells, Bedaquiline, Fenofibrate -- Intellectual property, Hydroxyprogesterone -- Intellectual property, Antibacterial agents -- Intellectual property, Antineoplastic agents -- Intellectual property, Antiprotozoan agents, Health, Women's issues/gender studies
Abstract

2020 DEC 10 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors LISANTI, [...]

Published
2020

21. 'Therapeutic Approaches For Treating Cmt And Related Disorders' in Patent Application Approval Process (USPTO 20200155491)

Subjects
Balsalazide -- Intellectual property, Fenofibrate -- Intellectual property, Felbamate, Methimazole -- Intellectual property, Phenoxybenzamine -- Intellectual property, Physical fitness, Loxapine, Dutasteride -- Intellectual property, Flumazenil -- Intellectual property, Obesity, Editors, Health
Abstract

2020 JUN 13 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent application by the inventors COHEN, Daniel (Saint Cloud, FR); CHUMAKOV, [...]

Published
2020

22. Patent Issued for Topical Formulations Having Enhanced Bioavailability (USPTO 10,588,859)

Subjects
Miglitol -- Intellectual property, Clemastine -- Intellectual property, Nalbuphine -- Intellectual property, Rifapentine -- Intellectual property, Dirithromycin -- Intellectual property, Paricalcitol, Valsartan, Halofantrine -- Intellectual property, Metronidazole -- Intellectual property, Povidone -- Intellectual property, Efavirenz -- Intellectual property, Oxaprozin -- Intellectual property, Fenofibrate -- Intellectual property, Physical fitness, Cilostazol -- Intellectual property, Tizanidine -- Intellectual property, Anticonvulsants -- Intellectual property, Telmisartan -- Intellectual property, Butenafine -- Intellectual property, Zileuton -- Intellectual property, Sibutramine -- Intellectual property, Death, Obesity, Vigabatrin, Tiagabine, Editors, Lamotrigine, Health
Abstract

2020 APR 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Berg LLC (Framingham, Massachusetts, United States) has been issued patent number 10,588,859, [...]

Published
2020

23. Patent Issued for Therapeutic Approaches For Treating CMT And Related Disorders (USPTO 10,441,558)

Subjects
Balsalazide -- Intellectual property, Fenofibrate -- Intellectual property, Felbamate, Methimazole -- Intellectual property, Phenoxybenzamine -- Intellectual property, Physical fitness, Loxapine, Dutasteride -- Intellectual property, Flumazenil -- Intellectual property, Obesity, Editors, Health
Abstract

2019 NOV 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Pharnext (Issy-les-Moulineaux, France) has been issued patent number 10,441,558, according to news [...]

Published
2019

25. Patent Issued for Phosphonium-based ionic drug conjugates (USPTO 11541120)

Subjects
Cefditoren -- Intellectual property, Homeopathy -- Materia medica and therapeutics, Tirofiban -- Intellectual property, Antineoplastic agents -- Intellectual property, Antilipemic agents -- Intellectual property, Nisoldipine -- Intellectual property, Emtricitabine -- Intellectual property, Alitretinoin -- Intellectual property, Antimitotic agents -- Intellectual property, Tranexamic acid -- Intellectual property, Angiotensin II receptor blockers, Esmolol -- Intellectual property, Fenofibrate -- Intellectual property, ACE inhibitors, Therapeutics -- Intellectual property, Clopidogrel -- Intellectual property, Adefovir dipivoxil -- Intellectual property, Antihypertensive drugs, Fenoprofen -- Intellectual property, Health
Abstract

2023 JAN 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity & Diabetes Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Kalaritis, [...]

Published
2023

36. 'Use Of Gemfibrozil And Derivative Thereof For Treatment And/Or Prevention Of Neurodegenerative Disease' in Patent Application Approval Process (USPTO 20220031643)

Subjects
Exelon Corp. -- Intellectual property, Fenofibrate -- Intellectual property, Electric utilities -- Intellectual property, Nervous system diseases -- Prevention, Gemfibrozil -- Intellectual property, Health, Psychology and mental health, Aricept (Medication) -- Intellectual property, Razadyne (Medication) -- Intellectual property, Namenda (Medication) -- Intellectual property
Abstract

2022 FEB 21 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- A patent application by the inventors LI, Guiyu (Kunming, CN); LUO, Rongcan (Kunming, [...]

Published
2022

42. 'Metabolic Biomarkers For The Identification And Characterization Of Alzheimers Disease' in Patent Application Approval Process (USPTO 20210293794)

Subjects
Fenofibrate -- Intellectual property, Amino acids -- Intellectual property, Alzheimer's disease, Health, Psychology and mental health
Abstract

2021 OCT 11 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- A patent application by the inventors Arnold, Matthias (Neuherberg, Bavaria, DE); Dehkordi, Siamak [...]

Published
2021

43. 'Self-Emulsifying Composition Of Omega3 Fatty Acid' in Patent Application Approval Process (USPTO 20210267927)

Subjects
Mochida Pharmaceutical Company Ltd. -- Intellectual property, Fenofibrate -- Intellectual property, Unsaturated fatty acids -- Intellectual property, Pharmaceutical industry -- Intellectual property, Business, Health
Abstract

2021 SEP 24 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- A patent application by the inventors FUJII, Hirosato (Tokyo, JP); ITO, Hiromitsu (Tokyo, [...]

Published
2021

44. Patent Application Titled 'Functionalized Long-Chain Hydrocarbon Mono- And Di-Carboxylic Acids And Their Use For The Prevention Or Treatment Of Disease' Published Online (USPTO 20210269384)

Subjects
Pentamidine isethionate -- Intellectual property, Homeopathy -- Materia medica and therapeutics, Antineoplastic agents -- Intellectual property, Organic acids, Liver cirrhosis, Antimitotic agents -- Intellectual property, Fenofibrate -- Intellectual property, Therapeutics -- Intellectual property, Hypoglycemic agents, Liver, Aminotransferases, Type 2 diabetes, Roflumilast -- Intellectual property, Health
Abstract

2021 SEP 20 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity & Diabetes Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent [...]

Published
2021

45. 'Azelaic Acid Esters In The Treatment Or Prevention Of Dyslipidemia And Associated Conditions' in Patent Application Approval Process (USPTO 20210251939)

Subjects
Fenofibrate -- Intellectual property, Esters -- Intellectual property, Antilipemic agents -- Intellectual property, Hypoglycemic agents, Cardiovascular diseases, Biotechnology industry, Pharmaceuticals and cosmetics industries, Health
Abstract

2021 SEP 12 (NewsRx) -- By a News Reporter-Staff News Editor at Heart Disease Weekly -- A patent application by the inventors IZBICKA, Elzbieta (San Antonio, TX, US); STREEPER, Robert [...]

Published
2021

46. 'Functionalized Long-Chain Hydrocarbon Mono- And Di-Carboxylic Acids And Their Use For The Prevention Or Treatment Of Disease' in Patent Application Approval Process (USPTO 20210221765)

Subjects
Pentamidine isethionate -- Intellectual property, Homeopathy -- Materia medica and therapeutics, Antineoplastic agents -- Intellectual property, Organic acids, Liver diseases -- Prevention, Antimitotic agents -- Intellectual property, Fenofibrate -- Intellectual property, Therapeutics -- Intellectual property, Hypoglycemic agents, Liver, Aminotransferases, Type 2 diabetes -- Prevention, Roflumilast -- Intellectual property, Health
Abstract

2021 AUG 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity & Diabetes Week -- A patent application by the inventor ONICIU, Daniela Carmen (Gainesville, FL, US), filed [...]

Published
2021

48. Researchers Submit Patent Application, 'Self-Emulsifying Composition Of Omega3 Fatty Acid', for Approval (USPTO 20210128510)

Subjects
Mochida Pharmaceutical Company Ltd. -- Intellectual property, Fenofibrate -- Intellectual property, Linolenic acids -- Intellectual property, Alcohols -- Intellectual property, Omega-3 fatty acids, Pharmaceutical industry -- Intellectual property, Business, Health
Abstract

2021 JUN 18 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors [...]

Published
2021

50. 'Agent For Treatment Of Pbc' in Patent Application Approval Process (USPTO 20210069157)

Subjects
Kowa Company Ltd. -- Intellectual property, Fenofibrate -- Intellectual property, Liver, Liver diseases, Pharmaceutical industry -- Intellectual property, Health
Abstract

2021 MAR 29 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity & Diabetes Week -- A patent application by the inventors NAKAMURA, Mitsumasa (Chuo-ku, JP); Kojima, Satoshi (Chuo-ku, [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results